Data Management and Sharing Plan for: A Phase 2 Trial Investigating Epcoritamab in Patient

A Data Management and Sharing Plan outlines the scientific data to be generated and used in a clinical research project. The plan describes a Phase 2 trial investigating the drug Epcoritamab in patients with previously treated Waldenstrom Macroglobulinemia. The document was authored by Christopher Dittus and last updated on April 27, 2026.

Use Cases

• Reviewing data governance frameworks for clinical trials based on the described management plan.
• Planning data sharing strategies for oncology research based on the outlined project strategy.
• Analyzing documentation standards for regulatory compliance based on the plan's structure.

Strengths

• Plan is specifically for a Phase 2 clinical trial, indicating a structured research context.
• Focuses on a defined patient population: those with previously treated Waldenstrom Macroglobulinemia.
• Author and last update date (2026-04-27) are explicitly provided.

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count and file formats are unknown, which may limit suitability assessment.

Provenance

Source

Dittus, Christopher; ODUM Harvested Dataverse

Collection Method

Harvested from a Dataverse repository, likely as a research document.

Time Range

Plan last updated 2026-04-27; trial timeframe is not specified.

Freshness

Last updated 2026-04-27 03:10:39; freshness should be verified.

Geography

Geographic coverage of the trial is not specified.